Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
13 Patents
#33 in Burnaby
#1,164 in Canada
#45,039 in the World
Qu Biologics Inc.
Forward Citations = 83
13 inventors:
Qu Biologics Inc.
% Expired Patents = 15.4
CIPO Patents = 1
EPO Patents = 5
Forward Citations = 83
Loading Chart...
Loading Chart...
13 inventors (with patents filed for the assignee):
Harold David Gunn (13 out of 18 patents)
Salim Dhanji (4 out of 6 patents)
David W Mullins (4 out of 5 patents)
4. Shirin Kalyan (2 out of 2 patents)
5. Mark Bazett (2 out of 2 patents)
6. Brett Anthony Premack (2 out of 9 patents)
7. Michael Tak Huai Chow (2 out of 2 patents)
8. Momir Bosiljcic (1 out of 1 patent)
9. Monan Angela Zhang (1 out of 1 patent)
10. Marcel Thalen (1 out of 1 patent)
11. Dermot McGovern (1 out of 8 patents)
12. Boyko Traychev Kabakchiev (1 out of 1 patent)
13. Ho Pan Sham (1 out of 1 patent)
14. Gunn Harold D D (0 patent)
13 patents:
6. 10086066 - Tissue targeted antigenic activation of the immune response to treat cancers (2018-10-02),
7. 9775896 - Tissue targeted antigenic activation of the immune response to treat cancers (2017-10-03),
8. 9320788 - Tissue targeted antigenic activation of the immune response to treat cancers (2016-04-26),
9. 9320787 - Tissue targeted antigenic activation of the immune response to treat cancers (2016-04-26),
10. 9107864 - Tissue targeted antigenic activation of the immune response to treat cancers (2015-08-18),
Company Overview
Qu Biologics Inc. is a biotechnology company based in Burnaby, Canada, focused on developing innovative therapies that harness the body's immune system to combat chronic diseases and cancer. The company specializes in immune modulation through its proprietary platform, which aims to restore immune function and promote healing. Qu Biologics is committed to advancing its research in immunotherapy, with a vision to provide effective treatment options that enhance the quality of life for patients facing serious health challenges.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Qu Biologics Inc.. Retrieved from https://idiyas.com/company/qu-biologics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
5 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]